Evidence map›Paper›PMID 25073432›Full record

ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2014

TGF-β signaling regulates fibrotic expression and activity in carpal tunnel syndrome.

Anne Gingery, Tai-Hua Yang, Sandra M Passe, Kai-Nan An, Chunfeng Zhao, Peter C Amadio

Open access · bronzeAbstract read
In one paragraph

Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effect of a monocyte chemoattractant protein-1 synthesis inhibitor on fibroblasts from patients with carpal tunnel syndrome.Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2021
    Article
  16. Blocking CTGF/CCN2 reverses neural fibrosis and sensorimotor declines in a rat model of overuse-induced median mononeuropathy.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Anne GingeryDepartment of Biochemistry and Molecular Biology, Biomechanics and Tendon & Soft Tissue Biology Laboratory, Mayo Clinic, Rochester, Minnesota.
Tai-Hua Yang
Sandra M Passe
Kai-Nan An
Chunfeng Zhao
Peter C Amadio
Mayo Clinic · US

Funding

Musculoskeletal Research Training ProgramT32AR056950 · NIAMS · MAYO CLINIC ROCHESTER · PI Jennifer J Westendorf · 2009 to 2026
$7.0M
Subsynovial Connective Tissue and Carpal Tunnel SyndromeR01AR049823 · NIAMS · MAYO CLINIC ROCHESTER · PI AMADIO, PETER C. · 2003 to 2011
$3.0M
Actions of Endoxifen on the SkeletonF32AR063596 · NIAMS · MAYO CLINIC ROCHESTER · PI GINGERY, ANNE · 2012 to 2013
$113k
NIAMS NIH HHS AR49823NIAMS NIH HHS F32 AR063596NIAMS NIH HHS R01 AR049823NIAMS NIH HHS T32 AR056950
6 · The paper itself

Abstract

Fibrosis of the subsynovial connective tissue (SSCT) is a predominant feature of carpal tunnel syndrome (CTS). While the nature of CTS has been extensively studied, little is known about the etiology of this disease. We investigated SSCT tissue from patients with CTS and control subjects using fibrosis arrays and cell culture analysis. Twofold changes in fibrotic gene expression were found in multiple genes from patient SSCT using fibrosis arrays. This data was confirmed via qRT-PCR on a subset of genes; collagen I (Col1), collagen III (Col3), connective tissue growth factor (CTGF), transforming growth factor β (TGF-β), and SMAD3 (P < 0.05) which significantly corroborate the fold changes found in the fibrosis arrays. To further explore the nature of SSCT fibrosis, cells were isolated from patient and control tissue. Col1, Col3, TGF-β, and SMAD3 were highly expressed in patient SSCT fibroblasts as compared to control (P < 0.05). Further, fibrotic genes expression was decreased by inhibiting TGF-β receptor I (TβRI) activity (P < 0.05). TGF-β second messenger SMAD activity was significantly activated in SSCT fibroblasts from patients and this activation was abrogated by inhibiting TβRI signaling (P < 0.05). These findings suggest that blocking TGF-β signaling may be an important therapeutic approach to treating the underlying fibrosis of SSCT in CTS patients.

Indexed as

Gene Expression RegulationSignal TransductionAdultBiopsyCadaverCarpal Tunnel SyndromeCollagen Type ICollagen Type IIIConnective Tissue Growth FactorFibroblastsFibrosisHumansMiddle AgedOligonucleotide Array Sequence AnalysisPteridinesSmad3 ProteinCCN2 protein, humanCollagen Type ICollagen Type IIIConnective Tissue Growth FactorPteridinesSD-208Smad3 ProteinSMAD3 protein, humanTransforming Growth Factor betacarpal tunnel syndromefibrosissubsynovial connective tissueTGF-β

Identifiers

PMID25073432
PMCPMC4222071
OpenAlexW1564067955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.